ADGRL3 (LPHN3) variants are associated with a refined phenotype of ADHD in the MTA study

被引:31
作者
Acosta, Maria T. [1 ,2 ]
Swanson, James [3 ,4 ]
Stehli, Annamarie [4 ]
Molina, Brooke S. G. [5 ,6 ]
Martinez, Ariel F. [1 ]
Arcos-Burgos, Mauricio [7 ]
Muenke, Maximilian [1 ]
机构
[1] NHGRI, Med Genet Branch, NIH, 35 Convent Dr,MSC 3717,Bldg 35,Room 1B203, Bethesda, MD 20892 USA
[2] George Washington Univ, Childrens Natl Med Ctr, Dept Pediat & Neurol, Washington, DC USA
[3] Florida Int Univ, Dept Psychiat, Miami, FL 33199 USA
[4] Univ Calif Irvine, Dept Pediat, Irvine, CA 92717 USA
[5] Univ Pittsburgh, Dept Psychiat, Pittsburgh, PA USA
[6] Univ Pittsburgh, Dept Psychol, Pittsburgh, PA 15260 USA
[7] Australian Natl Univ, Genom & Predict Med, Genome Biol Dept, John Curtin Sch Med Res,ANU Coll Med Biol & Envir, Bldg 131 Garran Rd, Canberra, ACT 2600, Australia
关键词
ADGRL3; ADHD; genetics; LPHN3; MTA; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT HYPERACTIVITY DISORDER; ADOLESCENT SUBSTANCE USE; FOLLOW-UP; SUSCEPTIBILITY; GENE; REPLICATION; CHILDREN;
D O I
10.1002/mgg3.230
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background ADHD is the most common neuropsychiatric condition affecting individuals of all ages. Long-term outcomes of affected individuals and association with severe comorbidities as SUD or conduct disorders are the main concern. Genetic associations have been extensively described. Multiple studies show that intronic variants harbored in the ADGRL3 (LPHN3) gene are associated with ADHD, especially associated with poor outcomes. Methods In this study, we evaluated this association in the Multimodal Treatment Study of children with ADHD (MTA), initiated as a 14-month randomized clinical trial of 579 children diagnosed with DSM-IV ADHD-Combined Type (ADHD-C), that transitioned to a 16-year prospective observational follow-up, and 289 classmates added at the 2-year assessment to serve as a local normative comparison group (LNCG). Diagnostic evaluations at entry were based on the Diagnostic Interview Schedule for Children-Parent (DISC-P), which was repeated at several points over the years. For an add-on genetic study, blood samples were collected from 232 in the MTA group and 139 in the LNCG. Results For the 205 MTA participants, 14.6% retained the DISC-P diagnosis of ADHD-C in adolescence. For 127 LNCG participants, 88.2% remained undiagnosed by the DISC-P. We genotyped 15 polymorphic SNP markers harbored in the ADGRL3 gene, and compared allele frequencies for the 30 cases with continued diagnosis of ADHD-C in adolescence to the other participants. Replication of the association of rs2345039 ADGRL3 variant was observed (P value = 0.004, FDR corrected = 0.03; Odds ratio = 2.25, upper CI 1.28-3.97). Conclusion The detection of susceptibility conferred by ADGRL3 variants in the extreme phenotype of continued diagnosis of ADHD-C from childhood to adolescence provides additional support that the association of ADGRL3 and ADHD is not spurious. Exploring genetic effects in longitudinal cohorts, in which refined, age-dependent phenotypes are documented, is crucial to understand the natural history of ADHD.
引用
收藏
页码:540 / 547
页数:8
相关论文
共 31 条
[1]   A two-locus genetic interaction between LPHN3 and 11q predicts ADHD severity and long-term outcome [J].
Acosta, M. T. ;
Velez, J. I. ;
Bustamante, M. L. ;
Balog, J. Z. ;
Arcos-Burgos, M. ;
Muenke, M. .
TRANSLATIONAL PSYCHIATRY, 2011, 1 :e17-e17
[2]   Attention-deficit/hyperactivity disorder in a population isolate: Linkage to loci at 4q13.2, 5q33.3, 11q22, and 17p11 [J].
Arcos-Burgos, M ;
Castellanos, FX ;
Pineda, D ;
Lopera, F ;
Palacio, JD ;
Palacio, LG ;
Rapoport, JL ;
Berg, K ;
Bailey-Wilson, JE ;
Muenke, M .
AMERICAN JOURNAL OF HUMAN GENETICS, 2004, 75 (06) :998-1014
[3]   A common variant of the latrophilin 3 gene, LPHN3, confers susceptibility to ADHD and predicts effectiveness of stimulant medication [J].
Arcos-Burgos, M. ;
Jain, M. ;
Acosta, M. T. ;
Shively, S. ;
Stanescu, H. ;
Wallis, D. ;
Domene, S. ;
Velez, J. I. ;
Karkera, J. D. ;
Balog, J. ;
Berg, K. ;
Kleta, R. ;
Gahl, W. A. ;
Roessler, E. ;
Long, R. ;
Lie, J. ;
Pineda, D. ;
Londono, A. C. ;
Palacio, J. D. ;
Arbelaez, A. ;
Lopera, F. ;
Elia, J. ;
Hakonarson, H. ;
Johansson, S. ;
Knappskog, P. M. ;
Haavik, J. ;
Ribases, M. ;
Cormand, B. ;
Bayes, M. ;
Casas, M. ;
Ramos-Quiroga, J. A. ;
Hervas, A. ;
Maher, B. S. ;
Faraone, S. V. ;
Seitz, C. ;
Freitag, C. M. ;
Palmason, H. ;
Meyer, J. ;
Romanos, M. ;
Walitza, S. ;
Hemminger, U. ;
Warnke, A. ;
Romanos, J. ;
Renner, T. ;
Jacob, C. ;
Lesch, K-P ;
Swanson, J. ;
Vortmeyer, A. ;
Bailey-Wilson, J. E. ;
Castellanos, F. X. .
MOLECULAR PSYCHIATRY, 2010, 15 (11) :1053-1066
[4]   A common genetic network underlies substance use disorders and disruptive or externalizing disorders [J].
Arcos-Burgos, Mauricio ;
Velez, Jorge I. ;
Solomon, Benjamin D. ;
Muenke, Maximilian .
HUMAN GENETICS, 2012, 131 (06) :917-929
[5]   Toward a better understanding of ADHD: LPHN3 gene variants and the susceptibility to develop ADHD [J].
Arcos-Burgos, Mauricio ;
Muenke, Maximilian .
ADHD-ATTENTION DEFICIT AND HYPERACTIVITY DISORDERS, 2010, 2 (03) :139-147
[6]   CONTROLLING THE FALSE DISCOVERY RATE - A PRACTICAL AND POWERFUL APPROACH TO MULTIPLE TESTING [J].
BENJAMINI, Y ;
HOCHBERG, Y .
JOURNAL OF THE ROYAL STATISTICAL SOCIETY SERIES B-STATISTICAL METHODOLOGY, 1995, 57 (01) :289-300
[7]   LPHN3 and attention-deficit/hyperactivity disorder: a susceptibility and pharmacogenetic study [J].
Bruxel, E. M. ;
Salatino-Oliveira, A. ;
Akutagava-Martins, G. C. ;
Tovo-Rodrigues, L. ;
Genro, J. P. ;
Zeni, C. P. ;
Polanczyk, G. V. ;
Chazan, R. ;
Schmitz, M. ;
Arcos-Burgos, M. ;
Rohde, L. A. ;
Hutz, M. H. .
GENES BRAIN AND BEHAVIOR, 2015, 14 (05) :419-427
[8]   LPHN3 and attention-deficit/hyperactivity disorder: interaction with maternal stress during pregnancy [J].
Choudhry, Zia ;
Sengupta, Sarojini M. ;
Grizenko, Natalie ;
Fortier, Marie-Eve ;
Thakur, Geeta A. ;
Bellingham, Johanne ;
Joober, Ridha .
JOURNAL OF CHILD PSYCHOLOGY AND PSYCHIATRY, 2012, 53 (08) :892-902
[9]   Screening of Human LPHN3 for Variants With a Potential Impact on ADHD Susceptibility [J].
Domene, Sabina ;
Stanescu, Horia ;
Wallis, Deeann ;
Tinloy, Bradford ;
Pineda, Daniel E. ;
Kleta, Robert ;
Arcos-Burgos, Mauricio ;
Roessler, Erich ;
Muenke, Maximilian .
AMERICAN JOURNAL OF MEDICAL GENETICS PART B-NEUROPSYCHIATRIC GENETICS, 2011, 156B (01) :11-18
[10]   Influence of a Latrophilin 3 (LPHN3) risk haplotype on event-related potential measures of cognitive response control in attention-deficit hyperactivity disorder (ADHD) [J].
Fallgatter, Andreas J. ;
Ehlis, Ann-Christine ;
Dresler, Thomas ;
Reif, Andreas ;
Jacob, Christian P. ;
Arcos-Burgos, Mauricio ;
Muenke, Maximilian ;
Lesch, Klaus-Peter .
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 (06) :458-468